Initiating Buprenorphine/Naloxone for Opioid Use Disorder in the Emergency Department
Keysha Low
- Vol. 43, Iss: 1, pp 12-22
TLDR
An overview of opioids, opioid use disorder, opioid agonist treatments such as buprenorphine/naloxone, and specifically details the program and protocol available in Alberta are provided.Abstract:
The opioid crisis continues to affect individuals across the country, and requires a multifaceted approach to minimize the impact of this public health crisis. Through the chronic consumption of opioids, many individuals can become dependent on opioids and develop opioid use disorder. Buprenorphine/naloxone is the recommended treatment for patients living with opioid use disorder. The Emergency Strategic Clinical Network™ within Alberta Health Services is targeting the crisis through emergency departments by implementing a provincially standardized program. The Buprenorphine/Naloxone Initiation in Emergency Departments program includes screening for opioid use disorder, treatment initiation with the medication buprenorphine/naloxone, and providing rapid and reliable referrals to community clinics for titration and continuing patient care. This paper provides an overview of opioids, opioid use disorder, opioid agonist treatments such as buprenorphine/naloxone, and specifically details the program and protocol available in Alberta.read more
References
More filters
Journal ArticleDOI
The Clinical Opiate Withdrawal Scale (COWS)
Donald R. Wesson,Walter Ling +1 more
TL;DR: The history of opiate withdrawal scales is reviewed and a template version of the COWS that can be copied and used clinically is appended.
Journal ArticleDOI
Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial
Gail D'Onofrio,Patrick G. O'Connor,Michael V. Pantalon,Marek C. Chawarski,Susan H. Busch,Patricia H. Owens,Steven L. Bernstein,David A. Fiellin +7 more
TL;DR: Among opioid-dependent patients, ED-initiated buprenorphine treatment vs brief intervention and referral significantly increased engagement in addiction treatment, reduced self-reported illicit opioid use, and decreased use of inpatient addiction treatment services but did not significantly decrease the rates of urine samples that tested positive for opioids or of HIV risk.
Journal ArticleDOI
Management of opioid use disorders: a national clinical practice guideline
Julie Bruneau,Keith Ahamad,Marie-Ève Goyer,Ginette Poulin,Peter Selby,Benedikt Fischer,T. Cameron Wild,Evan Wood +7 more
TL;DR: Opioid use disorder is one of the most challenging forms of addiction facing the Canadian health care system, and a major contributor to the marked rises in opioid-related morbidity and death that Canada has been experiencing.
Journal ArticleDOI
A Brief History of the Opioid Epidemic and Strategies for Pain Medicine
Mark R. Jones,Omar Viswanath,Jacquelin Peck,Alan D. Kaye,Jatinder S. Gill,Thomas T. Simopoulos +5 more
TL;DR: Improvement in abuse deterrent strategies which is a major focus of the Food and Drug Administration for all opioid preparations will likely play an important role by increasing the safety of these medications.
Journal ArticleDOI
Opioid Addiction and Abuse in Primary Care Practice: A Comparison of Methadone and Buprenorphine as Treatment Options
TL;DR: The literature on differences between buprenorphine and methadone regarding availability, efficacy, safety, side-effects, and dosing is reviewed, identifying resources for enhancing the effectiveness of medication-assisted recovery through coordination with behavioral/psychological counseling, embedded in the context of recovery-oriented systems of care.